Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Dechra Pharmaceuticals PLC Director's Dealing 2016

Mar 18, 2016

4797_dirs_2016-03-18_2d504864-fcca-4326-bc97-f00a85c1da90.html

Director's Dealing

Open in viewer

Opens in your device viewer

National Storage Mechanism | Additional information

You don't have Javascript enabled. For full functionality this page requires javascript to be enabled.

RNS Number : 6290S

Dechra Pharmaceuticals PLC

18 March 2016

18 March 2016

Dechra® Pharmaceuticals PLC

(Dechra or the Company)

Director shareholding 

Exercise of LTIP options:

Dechra Pharmaceuticals PLC announces that on 17 March 2016, the following Directors exercised nil cost options over ordinary shares of 1p each in the Company. The options were granted to them on 5 March 2013 pursuant to the Dechra Pharmaceuticals PLC Long Term Incentive Plan (the LTIP).

Ian Page sold sufficient shares (acquired pursuant to the LTIP exercise) in order to fund the resulting tax liability.  

Name Capacity Options Exercised Shares Sold Sale Price

per share
Total beneficial shareholding following this announcement Percentage of issued share capital
Ian Page Director 87,905 41,440 £12.100186 752,166 0.812%
Tony Griffin Director 32,027 Nil N/A 52,104 0.056%

The exercise of the options was subject to the achievement of performance conditions which vested at 93.1% of the total award.

For further information, please contact:

Suzana Cross, General Counsel and Company Secretary                

Telephone number: 01606 814730

About Dechra

Dechra is an international specialist veterinary pharmaceuticals and related products business.  Our expertise is in the development, manufacture, and sales and marketing of high quality products exclusively for veterinarians worldwide. Dechra's business is unique as the majority of its products are used to treat medical conditions for which there is no other effective solution or have a clinical or dosing advantage over competitor products.  For more information please visit: www.dechra.com

Trademarks

Dechra and the Dechra "D" logo are registered trademarks of Dechra Pharmaceuticals PLC.

This information is provided by RNS

The company news service from the London Stock Exchange

END

RDSAKFDDPBKDNND